We are live on
!
Find out more
Summit Therapeutics
SMMT
SMMT
206 hedge funds and large institutions have $2.06B invested in Summit Therapeutics in 2025 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 75 increasing their positions, 65 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
15% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 65
1.42% more ownership
Funds ownership: 13.85% → 15.27% (+1.4%)
3% less capital invested
Capital invested by funds: $2.12B → $2.06B (-$64.2M)
11% less funds holding
Funds holding: 232 → 206 (-26)
28% less call options, than puts
Call options by funds: $52.1M | Put options by funds: $72.2M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
42% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 60
Holders
206
Holders Change
-26
Holders Change %
-11.21%
% of All Funds
2.51%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
35
Increased
75
Reduced
65
Closed
60
Calls
$52.1M
Puts
$72.2M
Net Calls
-$20.2M
Net Calls Change
-$43.7M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$90.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$83.6M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$50.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$42.8M |
| 5 |
BlackRock
New York
|
+$37.6M |
